Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-524-327"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-10-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"pt"^^xsd:language2
lpv:document identification number	"en.20121023.45.2-524-327"2
lpv:hasSubsequent	lp_eu:2012-10-23-Speech-2-524-3352
lpv:speaker	lp:Maria do Céu Patrão Neves2
lpv:spokenAs	member; EPP (2009-07-14--2014-06-30)3 unknown; Partido Social Democrata (2009-07-14--2014-06-30)3 substitute; AGRI (2012-01-19--2014-06-30)3 member; PECH (2012-01-19--2014-06-30)3 member; Delegation for relations with Canada (2009-09-16--2014-06-30)3 substitute; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3
lpv:translated text	"On 16 July 2012 the European Commission adopted, under the European Globalisation Adjustment Fund (EGF), a new proposal for a decision on the mobilisation of the EGF in favour of Sweden in order to support the reintegration in the labour market of workers made redundant due to major structural changes in world trade patterns due to globalisation. This is the sixth application to be examined under the 2012 budget and refers to the mobilisation of a total amount of EUR 4 325 854 from the EGF for 543 redundancies in AstraZeneca during the four-month reference period from 15 June 2011 to 15 October 2011. A further 444 redundancies (987 in total) occurred before and after the reference period and are related to the same collective redundancy procedure. With this procedure having been assessed by all of the parties involved, particularly the European Commission, and with the Committee on Employment and Social Affairs having been associated to the process and being in favour of the Fund being mobilised for Sweden, I voted in favour of this report."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph